On 4/7/2017, Shares of Community Health Systems, Inc. (NYSE:CYH) closed at $8.86 in last trading day. After noting the initial trading entry at $8.91, it reached to a day’s high of $8.93 and moved to a day’s low of $8.74. The recent daily volume was 1.74 million as contrast to it’s an average volume of 4.04 million.
The last close of the Community Health Systems, Inc. stock reflects that it traded up +5.09% from its 50-day moving average of $8.43. The stock traded above +13.72% to its 200-day MA of $7.79. Furthermore, it moved lower -50.03% from its 52-week high of $17.73 and +113.49% up from $4.15, which is 52-week low of the stock.
Community Health Systems, Inc.’s (CYH) moved with shift of -0.11% in the past week. Over the last three months, the shares of the company have changed 44.07% and performed -19.01% over the last six months. The stock currently has Monthly Volatility of 5.27% and Weekly Volatility of 4.52%.
Community Health Systems, Inc., together with its subsidiaries, owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at urgent care centers, occupational medicine clinics, imaging centers, cancer centers, ambulatory surgery centers, and home health and hospice agencies. As of December 31, 2016, it owned or leased 155 hospitals, including 152 general acute care hospitals and 3 stand-alone rehabilitation or psychiatric hospitals with an aggregate of 26,222 licensed beds in 21 states. The company was founded in 1985 and is headquartered in Franklin, Tennessee.
Syneron Medical Ltd. (NASDAQ:ELOS) finalized the last transaction at value of $11.15, with a daily change of -0.45% or -0.05 points. The company maintained volume of 514.45 thousand shares. In past trading day, the stock hit the maximum price of $11.20 and touched to minimum value of $11.15. It has a market cap of $ 390.45M.
As of last trade close, the stock is trading downside -0.89% from its one year high of $11.25 and moved +80.42% upward from $6.18, which is one year low of the stock.
The stock traded above +11.28% from its 50-day moving average of $10.02. Furthermore, the stock moved up +32.67% to its 200-day MA of $ 8.40.
During the last month, Syneron Medical Ltd.’s (ELOS) has changed 11.50% and performed 51.29% over the last 6 months. The mean rating score for this stock is at 2.50. This rating scale contains from 1 to 5 with 5 representing a Strong Sell, 1 signifying a Strong Buy and 3 demonstrating a Hold. The Volatility was noted at 3.20% in recent month and observed Weekly Volatility of 1.32%.
Syneron Medical Ltd., together with its subsidiaries, researches, develops, manufactures, markets, and sells aesthetic medical products worldwide. The company develops products based on its proprietary Electro-Optical Synergy technology, which uses the synergy between electrical energy and optical energy to provide aesthetic medical treatments. It offers products, which are used for various non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, laser-assisted lipolysis, and tattoo removal. The company also provides cosmetic and aesthetic lasers, and light-based systems used by physicians and personal care practitioners; non-invasive technologies for fat cell destruction and body sculpting; and Viador system, a handheld device with a radiofrequency-needle array for use in transdermal delivery of biologic drug-products through a system-specific skin patch. It sells its products to dermatologists, plastic surgeons, other cosmetic physicians, qualified practitioners, and aestheticians and medical spas through direct sales force and distributors; and directly to end-users. Syneron Medical Ltd. was founded in 2000 and is headquartered in Yokneam Illit, Israel.